tiprankstipranks
Trending News
More News >
Ibio Inc (IBIO)
NASDAQ:IBIO
US Market

Ibio (IBIO) Stock Forecast & Price Target

Compare
2,117 Followers
See the Price Targets and Ratings of:

IBIO Financial Forecast

IBIO Earnings Forecast

Next quarter’s earnings estimate for IBIO is -$0.32 with a range of -$0.39 to -$0.25. The previous quarter’s EPS was -$0.48. IBIO beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 44.00% of the time in the same period. In the last calendar year IBIO has Outperformed its overall industry.
Next quarter’s earnings estimate for IBIO is -$0.32 with a range of -$0.39 to -$0.25. The previous quarter’s EPS was -$0.48. IBIO beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 44.00% of the time in the same period. In the last calendar year IBIO has Outperformed its overall industry.

IBIO Sales Forecast

Next quarter’s sales forecast for IBIO is $100.00K with a range of $0.00 to $200.00K. The previous quarter’s sales results were $200.00K. IBIO beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 46.38% of the time in the same period. In the last calendar year IBIO has Outperformed its overall industry.
Next quarter’s sales forecast for IBIO is $100.00K with a range of $0.00 to $200.00K. The previous quarter’s sales results were $200.00K. IBIO beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 46.38% of the time in the same period. In the last calendar year IBIO has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lucid Capital
$6
Buy
400.00%
Upside
Initiated
12/17/24
iBio initiated with a Buy at Lucid CapitaliBio initiated with a Buy at Lucid Capital
Brookline Capital Markets
$3.6
Buy
200.00%
Upside
Initiated
07/22/24
iBio initiated with a Buy at BrooklineiBio initiated with a Buy at Brookline
Chardan Capital
$5
Buy
316.67%
Upside
Reiterated
06/03/24
Analysts Offer Insights on Healthcare Companies: Ibio (NYSE MKT: IBIO) and Werewolf Therapeutics (NASDAQ: HOWL)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lucid Capital
$6
Buy
400.00%
Upside
Initiated
12/17/24
iBio initiated with a Buy at Lucid CapitaliBio initiated with a Buy at Lucid Capital
Brookline Capital Markets
$3.6
Buy
200.00%
Upside
Initiated
07/22/24
iBio initiated with a Buy at BrooklineiBio initiated with a Buy at Brookline
Chardan Capital
$5
Buy
316.67%
Upside
Reiterated
06/03/24
Analysts Offer Insights on Healthcare Companies: Ibio (NYSE MKT: IBIO) and Werewolf Therapeutics (NASDAQ: HOWL)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ibio

Which Analyst Should I Follow If I Want to Buy IBIO and Sell After:
1 Month
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-14.95%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -14.95% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-20.75%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -20.75% per trade.
1 Year
Keay NakaeChardan Capital
Success Rate
0/2 ratings generated profit
0%
Average Return
-37.05%
reiterated a buy rating 10 months ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -37.05% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-49.95%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -49.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IBIO Analyst Recommendation Trends

Rating
Nov 23
May 24
Jun 24
Jul 24
Dec 24
Strong Buy
0
1
2
3
3
Buy
0
0
0
0
0
Hold
3
2
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, IBIO has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IBIO average Analyst price target in the past 3 months is $6.00.
Each month's total comprises the sum of three months' worth of ratings.

IBIO Stock Forecast FAQ

What is IBIO’s average 12-month price target, according to analysts?
Based on analyst ratings, Ibio Inc’s 12-month average price target is $6.00.
    What is IBIO’s upside potential, based on the analysts’ average price target?
    Ibio Inc has 400.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is IBIO a Buy, Sell or Hold?
          Ibio Inc has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Ibio Inc’s price target?
            The average price target for Ibio Inc is $6.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $6.00 ,the lowest forecast is $6.00. The average price target represents 400.00% Increase from the current price of $1.2.
              What do analysts say about Ibio Inc?
              Ibio Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of IBIO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis